The Paul G. Allen Frontiers Group is a Seattle-based bioscience research initiative started in 2016 and funded with an initial investment of $100 million.
[2] Its vision is to identify areas in bioscience that are ripe for a major breakthrough, and then fund specific investigators to pursue advances.
[4] Allen Distinguished Investigators The Distinguished Investigator program "awards grants of $1.5 million of three years in support of early-stage research in biology and medicine that would not otherwise be supported by traditional funding sources.
This article about an organization in the United States is a stub.
You can help Wikipedia by expanding it.This article about a biology organization is a stub.